Advances in mathematical models of the active targeting of tumor cells by functional nanoparticles

BACKGROUND AND OBJECTIVE The process of nanoparticles (NPs) entering blood circulation to actively target tumor cells involves four stages-the transport of NPs in blood vessels, transvascular transport of NPs, transport of NPs in the tumor interstitial matrix and entry of NPs into tumor cells. These four stages are a complex process involving mechanical, physical, biochemical, and biophysical factors, the tumor microenvironment (TME) and properties of NPs play important roles in this process. Because this process involves a large number of factors and is very complex, it is difficult to study with conventional methods. METHODS Using mathematical models for simulation is suitable for addressing this complex situation and can describe the complexity well. RESULTS This work focuses on the theoretical simulation of NPs that target tumor cells to illustrate the effects of the abnormal microenvironment of tumors and properties of NPs on the transport process. Mathematical models constructed by different methods are enumerated. Through studying these mathematical models, different methods to overcome nanoparticle (NP) transport obstacles are illustrated. CONCLUSIONS It is necessary to construct a theoretical model of active targeting nanodrug delivery under the coupling of micro-flow field and specific binding force field, and to simulate and analyze the delivery process at mesoscopic scale using computational fluid dynamics (CFD) method, so as to reveal the law and characteristics of drug delivery and cell uptake in the micro-environment of tumors in vivo. The methods and techniques discussed can serve as the basis for systematic studies of active targeting of functional nanoparticles to tumor cells.

[1]  Robert J. Gillies,et al.  Current Advances in Mathematical Modeling of Anti-Cancer Drug Penetration into Tumor Tissues , 2013, Front. Oncol..

[2]  P. Kantoff,et al.  Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.

[3]  Heiko Enderling,et al.  Formalizing an integrative, multidisciplinary cancer therapy discovery workflow. , 2013, Cancer research.

[4]  R. Jain,et al.  Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner , 2012, Nature nanotechnology.

[5]  R K Jain,et al.  Openings between defective endothelial cells explain tumor vessel leakiness. , 2000, The American journal of pathology.

[6]  H. Maeda,et al.  The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. , 2013, Advanced drug delivery reviews.

[7]  Subra Suresh,et al.  Size‐Dependent Endocytosis of Nanoparticles , 2009, Advanced materials.

[8]  M Ferrari,et al.  The adhesive strength of non-spherical particles mediated by specific interactions. , 2006, Biomaterials.

[9]  R. Jain,et al.  Strategies for advancing cancer nanomedicine. , 2013, Nature materials.

[10]  Dai Fukumura,et al.  A nanoparticle size series for in vivo fluorescence imaging. , 2010, Angewandte Chemie.

[11]  Ting-Ting Liu,et al.  Combined spectroscopies and molecular docking approach to characterizing the binding interaction of enalapril with bovine serum albumin. , 2017, Luminescence : the journal of biological and chemical luminescence.

[12]  Paolo Decuzzi,et al.  On the near-wall accumulation of injectable particles in the microcirculation: smaller is not better , 2013, Scientific Reports.

[13]  Triantafyllos Stylianopoulos,et al.  Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. , 2011, Annual review of chemical and biomolecular engineering.

[14]  Dae-Duk Kim,et al.  Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor. , 2009, International journal of pharmaceutics.

[15]  Junda Zheng,et al.  Numerical simulation of particle transport and deposition in the pulmonary vasculature. , 2014, Journal of biomechanical engineering.

[16]  Ying Li,et al.  Multiscale modeling and uncertainty quantification in nanoparticle-mediated drug/gene delivery , 2014 .

[17]  Mauro Ferrari,et al.  The Transport of Nanoparticles in Blood Vessels: The Effect of Vessel Permeability and Blood Rheology , 2008, Annals of Biomedical Engineering.

[18]  Say Chye Joachim Loo,et al.  Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE–cadherin , 2013, Nature Communications.

[19]  Mary E Napier,et al.  More effective nanomedicines through particle design. , 2011, Small.

[20]  Mauro Ferrari,et al.  Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.

[21]  Toru Hyakutake,et al.  Numerical simulation of red blood cell distributions in three-dimensional microvascular bifurcations. , 2015, Microvascular research.

[22]  Huajian Gao,et al.  Phase diagrams and morphological evolution in wrapping of rod-shaped elastic nanoparticles by cell membrane: a two-dimensional study. , 2014, Physical review. E, Statistical, nonlinear, and soft matter physics.

[23]  Warren C W Chan,et al.  The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.

[24]  Baoquan Ding,et al.  Tunable Rigidity of (Polymeric Core)–(Lipid Shell) Nanoparticles for Regulated Cellular Uptake , 2015, Advanced materials.

[25]  F. Jiang,et al.  Multi-spectroscopic analysis and molecular modeling on the interaction of curcumin and its derivatives with human serum albumin: a comparative study. , 2014, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[26]  H. Daniel Ou-Yang,et al.  The influence of size, shape and vessel geometry on nanoparticle distribution , 2013, Microfluidics and nanofluidics.

[27]  Samir Mitragotri,et al.  Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Triantafyllos Stylianopoulos,et al.  The role of mechanical forces in tumor growth and therapy. , 2014, Annual review of biomedical engineering.

[29]  S. Pun,et al.  Increased nanoparticle penetration in collagenase-treated multicellular spheroids , 2007, International journal of nanomedicine.

[30]  Ruth Nussinov,et al.  Close‐Range Electrostatic Interactions in Proteins , 2002, Chembiochem : a European journal of chemical biology.

[31]  Matija Snuderl,et al.  Coevolution of solid stress and interstitial fluid pressure in tumors during progression: implications for vascular collapse. , 2013, Cancer research.

[32]  Gerhard Gompper,et al.  Margination of micro- and nano-particles in blood flow and its effect on drug delivery , 2014, Scientific Reports.

[33]  Xiaoyuan Chen,et al.  Size Dependent Kinetics of Gold Nanorods in EPR Mediated Tumor Delivery , 2016, Theranostics.

[34]  Triantafyllos Stylianopoulos,et al.  Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside. , 2018, Trends in cancer.

[35]  H. Yao,et al.  Cooperative entry of nanoparticles into the cell , 2014 .

[36]  Ricky T. Tong,et al.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer , 2004, Nature Medicine.

[37]  Kai Yang,et al.  Computer simulation of the translocation of nanoparticles with different shapes across a lipid bilayer. , 2010, Nature nanotechnology.

[38]  Rakesh K. Jain,et al.  Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors , 2004, Cancer Research.

[39]  A. Zhang,et al.  Study of non-uniform nanoparticle liposome extravasation in tumour , 2005, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[40]  Min Wu,et al.  The effect of interstitial pressure on tumor growth: coupling with the blood and lymphatic vascular systems. , 2013, Journal of theoretical biology.

[41]  R. Jain,et al.  Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. , 2014, Cancer cell.

[42]  Yu-qiang Ma,et al.  Designing nanoparticle translocation through membranes by computer simulations. , 2012, ACS nano.

[43]  Triantafyllos Stylianopoulos,et al.  Diffusion anisotropy in collagen gels and tumors: the effect of fiber network orientation. , 2010, Biophysical journal.

[44]  R. Jain,et al.  Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.

[45]  Huajian Gao,et al.  Rotation-Facilitated Rapid Transport of Nanorods in Mucosal Tissues. , 2016, Nano letters.

[46]  Jedd D. Wolchok,et al.  The future of cancer treatment: immunomodulation, CARs and combination immunotherapy , 2016, Nature Reviews Clinical Oncology.

[47]  Mauro Ferrari,et al.  In silico vascular modeling for personalized nanoparticle delivery. , 2013, Nanomedicine.

[48]  Vivek Shrivastava,et al.  Cancer Therapeutics- Opportunities, Challenges and Advances in Drug Delivery , 2011 .

[49]  Yu-qiang Ma,et al.  Role of physicochemical properties of coating ligands in receptor-mediated endocytosis of nanoparticles. , 2012, Biomaterials.

[50]  Leaf Huang,et al.  Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[51]  David A. Jaffray,et al.  A Mathematical Model of the Enhanced Permeability and Retention Effect for Liposome Transport in Solid Tumors , 2013, PloS one.

[52]  R. Lipowsky,et al.  Cooperative wrapping of nanoparticles by membrane tubes. , 2014, Soft matter.

[53]  Gerhard Gompper,et al.  Understanding particle margination in blood flow - A step toward optimized drug delivery systems. , 2016, Medical engineering & physics.

[54]  Kai Yang,et al.  Cooperative Transmembrane Penetration of Nanoparticles , 2015, Scientific Reports.

[55]  M. Ferrari,et al.  A Theoretical Model for the Margination of Particles within Blood Vessels , 2005, Annals of Biomedical Engineering.

[56]  Yingchun Liu,et al.  Molecular basis for the targeted binding of RGD-containing peptide to integrin αVβ3. , 2014, Biomaterials.

[57]  S. Sahu,et al.  Facile preparation of multifunctional hollow silica nanoparticles and their cancer specific targeting effect. , 2013, Biomaterials science.

[58]  Jie Yang,et al.  Coupled Particulate and Continuum Model for Nanoparticle Targeted Delivery. , 2013, Computers & structures.

[59]  Ming-Zher Poh,et al.  Diffusion of particles in the extracellular matrix: the effect of repulsive electrostatic interactions. , 2010, Biophysical journal.

[60]  Timothy W. Secomb,et al.  Transport of drugs from blood vessels to tumour tissue , 2017, Nature Reviews Cancer.

[61]  Qi Wang,et al.  Molecular dynamics study on DNA nanotubes as drug delivery vehicle for anticancer drugs. , 2017, Colloids and surfaces. B, Biointerfaces.

[62]  Cyrus K Aidun,et al.  Effects of shear rate, confinement, and particle parameters on margination in blood flow. , 2016, Physical review. E.

[63]  Jinming Gao,et al.  Modeling particle shape-dependent dynamics in nanomedicine. , 2011, Journal of nanoscience and nanotechnology.

[64]  Huajian Gao,et al.  A non-equilibrium thermodynamic model for tumor extracellular matrix with enzymatic degradation , 2017 .

[65]  Antony Thomas,et al.  Influence of Red Blood Cells on Nanoparticle Targeted Delivery in Microcirculation. , 2011, Soft matter.

[66]  Michael S. Strano,et al.  Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles. , 2009, ACS nano.

[67]  R. Jain Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  Xing Hua Shi,et al.  Advances in the understanding of nanomaterial-biomembrane interactions and their mathematical and numerical modeling. , 2013, Nanomedicine.

[69]  S. A. Dergunov,et al.  Permission to enter cell by shape: nanodisk vs nanosphere. , 2012, ACS applied materials & interfaces.

[70]  Chor Yong Tay,et al.  Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood. , 2015, Chemical Society reviews.

[71]  Jifu Tan,et al.  Computational Modeling of Nanoparticle Targeted Drug Delivery , 2012 .

[72]  Wei Chen,et al.  Bioconjugated nanoparticle detection of respiratory syncytial virus infection , 2007, International journal of nanomedicine.

[73]  N. Kawazoe,et al.  Insight into the interactions between nanoparticles and cells. , 2017, Biomaterials science.

[74]  Xianren Zhang,et al.  Cooperative effect in receptor-mediated endocytosis of multiple nanoparticles. , 2012, ACS nano.

[75]  Yingchun Liu,et al.  Modeling the interaction of interferon α-1b to bovine serum albumin as a drug delivery system. , 2014, The journal of physical chemistry. B.

[76]  Huajian Gao,et al.  Surface-structure-regulated penetration of nanoparticles across a cell membrane. , 2012, Nanoscale.

[77]  Dai Fukumura,et al.  Cationic Nanoparticles Have Superior Transvascular Flux into Solid Tumors: Insights from a Mathematical Model , 2012, Annals of Biomedical Engineering.

[78]  M Ferrari,et al.  Flow chamber analysis of size effects in the adhesion of spherical particles , 2007, International journal of nanomedicine.

[79]  R. Jain,et al.  Cancer imaging by optical coherence tomography: preclinical progress and clinical potential , 2012, Nature Reviews Cancer.

[80]  C. Pozrikidis,et al.  Numerical simulation of blood and interstitial flow through a solid tumor , 2010, Journal of mathematical biology.